These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9170171)
1. Biologically based validation of PC electrophysiology data collection systems utilizing the Good Automated Laboratory Practices. Jones RD; Weyrauch TA; Bailey SR; Halder CA Qual Assur; 1997; 5(1):1-17. PubMed ID: 9170171 [TBL] [Abstract][Full Text] [Related]
2. Quality assurance responsibilities as defined by the EPA Good Automated Laboratory Practices (GALPs). Fielder FG; Eleuteri BA; Gross EM Qual Assur; 1993; 2(1-2):175-9. PubMed ID: 8156208 [TBL] [Abstract][Full Text] [Related]
3. In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test. Hayashi M; MacGregor JT; Gatehouse DG; Blakey DH; Dertinger SD; Abramsson-Zetterberg L; Krishna G; Morita T; Russo A; Asano N; Suzuki H; Ohyama W; Gibson D; Mutat Res; 2007 Feb; 627(1):10-30. PubMed ID: 17157053 [TBL] [Abstract][Full Text] [Related]
4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
5. In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring. Hayashi M; MacGregor JT; Gatehouse DG; Adler ID; Blakey DH; Dertinger SD; Krishna G; Morita T; Russo A; Sutou S Environ Mol Mutagen; 2000; 35(3):234-52. PubMed ID: 10737958 [TBL] [Abstract][Full Text] [Related]
6. Good Automated Laboratory Practices and other standards: validation of computer systems in the PC environment. Nitahara K Qual Assur; 1993; 2(1-2):96-101. PubMed ID: 8156229 [TBL] [Abstract][Full Text] [Related]
7. How to anticipate the assessment of the public health benefit of new medicines? Massol J; Puech A; Boissel JP; Therapie; 2007; 62(5):427-35. PubMed ID: 18206104 [TBL] [Abstract][Full Text] [Related]
8. Risk-based assessment applied to QA GLP audits. How to fulfill regulatory requirements while making the best use of our common sense, knowledge, talents, and resources? Piton A Ann Ist Super Sanita; 2008; 44(4):379-84. PubMed ID: 19352000 [TBL] [Abstract][Full Text] [Related]
9. [Digital data collection and analysis in clinical electrophysiology. A PC program for electrophysiology]. Walter P; Brunner R Klin Monbl Augenheilkd; 1994 Jan; 204(1):24-9. PubMed ID: 8152192 [TBL] [Abstract][Full Text] [Related]
10. Validation of a Monte Carlo simulation of the Philips Allegro/GEMINI PET systems using GATE. Lamare F; Turzo A; Bizais Y; Le Rest CC; Visvikis D Phys Med Biol; 2006 Feb; 51(4):943-62. PubMed ID: 16467589 [TBL] [Abstract][Full Text] [Related]
11. The application of an automated allele concordance analysis system (CompareCalls) to ensure the accuracy of single-source STR DNA profiles. Ryan JH; Barrus JK; Budowle B; Shannon CM; Thompson VW; Ward BE J Forensic Sci; 2004 May; 49(3):492-9. PubMed ID: 15171165 [TBL] [Abstract][Full Text] [Related]
12. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH). Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675 [TBL] [Abstract][Full Text] [Related]
13. Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studies. Sukovaty RL; Lee JW; Fox J; Toney K; Papac DI; Grover TA; Wells DS J Pharm Biomed Anal; 2006 Sep; 42(2):261-71. PubMed ID: 16765549 [TBL] [Abstract][Full Text] [Related]
14. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation. Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131 [TBL] [Abstract][Full Text] [Related]
15. PASSCLAIM - Synthesis and review of existing processes. Richardson DP; Affertsholt T; Asp NG; Bruce A; Grossklaus R; Howlett J; Pannemans D; Ross R; Verhagen H; Viechtbauer V Eur J Nutr; 2003 Mar; 42 Suppl 1():I96-111. PubMed ID: 12664324 [TBL] [Abstract][Full Text] [Related]
16. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]
17. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status. Box RJ; Spielmann H Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470 [TBL] [Abstract][Full Text] [Related]
18. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1. Lunsford LD; Flickinger JC; Larson D Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030 [TBL] [Abstract][Full Text] [Related]
19. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
20. Electrophysiology and pathology evaluation of the Yucatan pig as a non-rodent animal model for regulatory and mechanistic toxicology studies. Jones RD; Stuart BP; Greufe NP; Landes AM Lab Anim; 1999 Oct; 33(4):356-65. PubMed ID: 10778784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]